Trial intelligence / Profile preview

Babaodan Capsule for Elevated Total Bilirubin in PBC

NCT06371196Phase 4Not yet recruiting

Start
Apr 2024
Primary completion
Jul 2025
Modality
Small Molecules
01

Overview

A Phase 4 trial of Babaodan in primary biliary cholangitis (PBC). Planned start Apr 2024; status: not yet recruiting.

02

Drugs

Babaodan
03

Conditions

primary biliary cholangitis (PBC)

Beyond the preview

Go deeper on NCT06371196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06371196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call